Literature DB >> 28333821

Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.

.   

Abstract

Given the increasing availability and complexity of genetic testing, it is imperative that the practicing obstetrician-gynecologist or other health care provider has a firm comprehension of the benefits, limitations, and risks of offering a specific genetic test, as well as the importance of appropriate pretest and posttest counseling. The purpose of this Committee Opinion is to provide an outline of how obstetrician-gynecologists and other health care providers can best incorporate these tests into their current practices and provide appropriate pretest and posttest counseling to patients. Obstetrician-gynecologists and other health care providers should determine which tests will be offered as the standard in their practices so that similar testing strategies are made available to all patients. Practices should have procedures in place that ensure timely disclosure of test results to patients. As with any medical test, expectations regarding the performance of a genetic test should be discussed with the patient before the test is ordered. After counseling, patients should have the option to decline any or all testing. Pretest and posttest counseling should be done in a clear, objective, and nondirective fashion, which allows patients sufficient time to understand information and make informed decisions regarding testing and further evaluation or treatment. In addition to counseling each patient about her own personal risk, obstetrician-gynecologists and other health care providers should counsel patients regarding the risk for family members, including their potential to have affected offspring.

Entities:  

Mesh:

Year:  2017        PMID: 28333821     DOI: 10.1097/AOG.0000000000002020

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

1.  The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.

Authors:  Fred H Menko; Jacqueline A Ter Stege; Lizet E van der Kolk; Kiki N Jeanson; Winnie Schats; Daoud Ait Moha; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

2.  Fertility care in the era of commercial direct-to-consumer home DNA kits: issues to ponder.

Authors:  Keren Rotshenker-Olshinka; Michael H Dahan
Journal:  J Assist Reprod Genet       Date:  2020-02-26       Impact factor: 3.412

3.  Expanded carrier screening in gamete donors of Venezuela.

Authors:  Maria Teresa Urbina; Isaac Benjamin; Randolfo Medina; José Jiménez; Laura Trías; Jorge Lerner
Journal:  JBRA Assist Reprod       Date:  2017-12-01

4.  OB/GYN residents' training, attitudes, and comfort level regarding genetics.

Authors:  Anastasia Kathrens-Gallardo; Lauren Propst; Edward Linn; Rachel Pothast; Catherine Wicklund; Aishwarya Arjunan
Journal:  J Assist Reprod Genet       Date:  2021-09-13       Impact factor: 3.412

5.  Integrating pharmacogenetic testing into primary care.

Authors:  Susanne B Haga
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-11-03

6.  Technology-Driven Noninvasive Prenatal Screening Results Disclosure and Management.

Authors:  Aishwarya Arjunan; Rotem Ben-Shachar; Jamie Kostialik; Katherine Johansen Taber; Gabriel A Lazarin; Elizabeth Denne; Dale Muzzey; Carrie Haverty
Journal:  Telemed J E Health       Date:  2019-02-26       Impact factor: 3.536

7.  Prenatal Genetic Screening and Diagnostic Testing: Assessing Patients' Knowledge, Clinical Experiences, and Utilized Resources in Comparison to Provider's Perceptions.

Authors:  Arlin Delgado; Jay Schulkin; Charles J Macri
Journal:  AJP Rep       Date:  2022-02-04

8.  GeneLiFT: A novel test to facilitate rapid screening of genetic literacy in a diverse population undergoing genetic testing.

Authors:  Hila Milo Rasouly; Nicole Cuneo; Maddalena Marasa; Natalia DeMaria; Debanjana Chatterjee; Jacqueline J Thompson; David A Fasel; Julia Wynn; Wendy K Chung; Paul Appelbaum; Chunhua Weng; Suzanne Bakken; Ali G Gharavi
Journal:  J Genet Couns       Date:  2020-12-26       Impact factor: 2.537

9.  Defining the Critical Components of Informed Consent for Genetic Testing.

Authors:  Kelly E Ormond; Maia J Borensztein; Miranda L G Hallquist; Adam H Buchanan; William Andrew Faucett; Holly L Peay; Maureen E Smith; Eric P Tricou; Wendy R Uhlmann; Karen E Wain; Curtis R Coughlin
Journal:  J Pers Med       Date:  2021-12-05

10.  Dealing with uncertain results from chromosomal microarray and exome sequencing in the prenatal setting: An international cross-sectional study with healthcare professionals.

Authors:  Celine Lewis; Jennifer Hammond; Jasmijn E Klapwijk; Eleanor Harding; Stina Lou; Ida Vogel; Emma J Szepe; Lisa Hui; Charlotta Ingvoldstad-Malmgren; Maria J Soller; Kelly E Ormond; Mahesh Choolani; Melissa Hill; Sam Riedijk
Journal:  Prenat Diagn       Date:  2021-03-30       Impact factor: 3.050

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.